AMLO announces that Patria vaccine against covid will be available in November

The Patria vaccine against covid-19which was developed by the National Council of Humanities, Sciences and Technologies (Conahcyt), will be available at the end of November of this year, the president announced Andrés Manuel López Obradorwho highlighted that the respective tests were carried out and their effectiveness against SARS-CoV-2 was proven.

After receiving the Abdala dose against the coronavirus and the influenza vaccine as part of the winter vaccination campaign, President López Obrador assured that Mexico now has its vaccine against the SARS-CoV-2 after its safety and effectiveness were proven.

We recommend: Vaccine Patria will be included in the new vaccination campaign against covid: Ssa

“The Patria vaccine is going very well, we are going to have the Patria vaccine this year, all the tests have already been done, the tests have already been passed, Mexico now has its vaccine, I think next month, at the end of November,” he said in his morning this Tuesday.

The president said that for this purpose also special laboratories were builtwith which the Patria injected vaccine against covid-19 is now a reality and authorization for its use by the Federal Commission for the Protection against Sanitary Risks (Cofepris) is imminent.

Patria vaccine against covid-19, with more than three years of development

The Patria vaccine against covid-19 led more than three years of development since in 2020 Conahcyt called on the scientific community and the productive sector to present proposals for Mexican vaccine developments against SARS-CoV-2. Among the projects sent, the one from Mexican laboratory Avimexwhose vaccine has since been called Patria.

This project was chosen for its degree of progress, rigor and scientific solidity. The Mexican laboratory determined that a recombinant Newcastle disease virus had the “potential for success” for the vaccine against Covid-19, so the development started from there.

In the preclinical testing applied to various species of animals, the vaccine candidate proved its effectiveness against covid-19, while in the clinical trials carried out to volunteers, the first of them in April 2021, its safety and effectiveness against said virus was confirmed.

After having passed all the tests, the Patria vaccine against covid-19 is in the last phase in which the Cofepris will grant you permission for its use as a reinforcement against the disease caused by SARS-CoV-2.

The Patria vaccine cost 937 million pesos through public-private investment. The federal government invested 422 million 897 thousand 939 pesos for the clinical development of the Mexican dose, while the rest corresponds to the investment provided by the Avimex laboratory.

vjcm